The cochlear radiation dose should be kept as low as possible in patients who receive simultaneous cisplatin-based chemotherapy. The risk of clinically relevant HL was shown when D exceeds 45 Gy independent of radiation technique or radiation regime. Cisplatin ototoxicity was shown to have a dose-dependent effect on bilateral SNHL, which was more pronounced in higher frequencies.
Two new sesquiterpene lactones, namely feruhodin A and feruhodin B, together with six known compounds, daucoeudesmanolactone, dehydrooopodin, oopodin, badkhysin, 7-demethylplastochromenol, and scoparone, were isolated from the roots of Ferula oopoda. The structures of these compounds were elucidated by 1D and 2D NMR techniques as well as high-resolution mass spectrometry. Cytotoxic effects of these compounds were evaluated against two human cancer cell lines including MCF7and K562 using the Alamar blue assay. The results showed that dehydrooopodin possessed significant cytotoxic effects with IC₅₀ values of 15 and 5 μM against MCF7 and K562, respectively.
High plan quality for complex spinal radiosurgery was achieved among all systems and all participating centers in this planning challenge. This study concludes that simple IMAT techniques can generate significantly better plan quality compared to previous established CKRS benchmarks.
PurposeThe brachytherapy with β‐ emitting ruthenium‐ plaques is a well‐established treatment for patients with choroidal melanoma. This treatment modality has been used in our department since January 2011.MethodsA retrospective study of 104 eyes with choroidal melanoma that were treated with ruthenium‐ brachytherapy between January 2011 and December 2014. Patients were followed for regression and associated side‐ effects. The study included patients that had a follow‐ up time of at least 3 months.ResultsOf the 104 melanomas nine also showed an infiltration of the ciliary body, 32 manifested at a central location and 59 eyes showed an exudative retinal detachment prior to brachytherapy. The mean sclera contact dose was 519 Gy, the mean apical dose applied was 105 Gy. The mean apical depth of the melanoma prior to therapy was 4.3 mm and after 12 months 2.2 mm. In three cases a movement of the plaques was necessary since the plaque did not cover the tumour margins in total because of the diameter of the melanomas. In eight cases the tumour showed regrowth after an initial regression was noticed. All together four eyes had to be removed. In eight cases distant metastasis were detected and two eyes showed a radiation retinopathy.ConclusionsFor the treatment of choroidal melanoma the β‐ emitting ruthenium‐ plaques represent a therapy with a local tumour control rate of 92.3% and eye salvaging rate of 96.2%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.